Letters, Testimony & Comments

BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
February 14 2012
By Electronic Submission To the State Intellectual Property Office, The Biotechnology Industry Organization (BIO) appreciates this...
December 9 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
October 27 2011
Dear Secretary Locke: On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...
May 13 2011
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that...
February 15 2011
RE: Participation of Malaysia in the Trans-Pacific Partnership Trade Negotiations Dear Ms. Blue: The Biotechnology Industry...
November 22 2010
October 14, 2010 To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological...
October 14 2010
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on India’s Department of Industrial...
September 29 2010
Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data...
July 26 2010
Intellectual Property Innovation and Chair of the Special 301 Committee Office of the United States Trade Representative Washington, D...
February 18 2010
Dear Ms. Blue, This letter is submitted by the Biotechnology Industry Organization (BIO) in response to the request for public comment...
November 3 2009
  VIEWS AND PROPOSALS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) AND THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF...
July 31 2009
U.S. Department of State
June 1 2009
Re: Docket No. FDA-2009-D-0675, OC 20091. Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug...
April 13 2009
Office of the U.S. Trade Representative
March 11 2009
Re: Special 301: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 73 Fed. Reg. 2958 (...
February 11 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an...
January 1 2008
Office of the U.S. Trade Representative
March 8 2007
Office of the U.S. Trade Representative
September 18 2006
To the State Intellectual Property Office of the People's Republic of China
August 28 2006
Letter to USTR on continuing concerns.
March 31 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.
March 24 2006
February 11 2005
Re: Docket No. 2004N-0115 Request for Comment on Prescription Drug Importation Dear Dr. Carmona and Members of the HHS Task Force on...
June 1 2004
TESTIMONY OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION BEFORE THE COMMITTEE ON HEALTH, EDUCATION, LABOR, & PENSIONS OF THE...
May 20 2004
April 14, 2004, 9:00 a.m. -5:00 p.m. Natcher Auditorium, Building 45, National Institutes of Health (NIH) 9000 Rockville Pike,...
April 14 2004
February 13 2004
The Honorable J. Dennis Hastert 235 Cannon House Office Building U.S. House of Representatives Washington DC 20510 Dear Speaker...
July 15 2003
The Honorable Mark B. McClellan Commissioner United States Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,...
February 14 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 29 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
November 27 2002
Every Year... -of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...
Government's role in developing solutions for diseases that disproportionately affect developing countries Introduction: -...
National Institutes of Health: An International Perspective NIH Mission: To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise WORLD HEALTH ORGANIZATION GENEVA—NOVEMBER 2007 THEODORE J. ROUMEL VICE PRESIDENT...

Letters, Testimony & Comments

April 26 2012
  The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission. Priority...
December 9 2011
By Electronic Submission To the State Intellectual Property Office, The Biotechnology Industry Organization (BIO) appreciates this...
October 27 2011
By electronic submission Saurabh Vishnubhakat Attorney Advisor, Office of Chief Economist United States Patent and Trademark...
May 13 2011
Dear Secretary Locke: On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...

Press Releases

February 21 2011
WASHINGTON, D.C. (Monday, February 21, 2011) - The Biotechnology Industry Organization (BIO) stresses the critical...
April 6 2010
WASHINGTON, D.C. (Tuesday, April 06, 2010) - The Obama Administration has made substantial progress to avoid...
March 2 2010
WASHINGTON, D.C. (Tuesday, March 02, 2010) - The Biotechnology Industry Organization (BIO) applauded today’s...
September 11 2008
WASHINGTON, D.C. (Thursday, September 11, 2008) - Today marks the fifth anniversary of the entry into force of...
May 21 2007
Washington, D.C. (May 21, 2007) — The Biotechnology Industry Organization (BIO) today announced a new forward-...